NEUROCRINE BIOSCIENCES INC Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Neurocrine Biosciences Inc quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Neurocrine Biosciences Inc Operating Lease, Payments for the quarter ending March 31, 2024 was $6.1M, a 38.6% increase year-over-year.
  • Neurocrine Biosciences Inc annual Operating Lease, Payments for 2023 was $17.9M, a 5.92% increase from 2022.
  • Neurocrine Biosciences Inc annual Operating Lease, Payments for 2022 was $16.9M, a 34.1% increase from 2021.
  • Neurocrine Biosciences Inc annual Operating Lease, Payments for 2021 was $12.6M, a 46.5% increase from 2020.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $17.9M +$1M +5.92% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-09
2022 $16.9M +$4.3M +34.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-09
2021 $12.6M +$4M +46.5% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-09
2020 $8.6M +$900K +11.7% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-09
2019 $7.7M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.